<DOC>
	<DOCNO>NCT02294942</DOCNO>
	<brief_summary>A double-blind , randomize , placebo-controlled , parallel study evaluate effect add-on RANCAD exercise tolerance angina frequency patient stable angina pectoris .</brief_summary>
	<brief_title>Extended-Release RANCAD Patients With Stable Angina Pectoris</brief_title>
	<detailed_description>Primary objective determine effect add-on RANCAD exercise treadmill test ( ETT ) duration trough plasma level RANCAD level 12-weeks therapy .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>1 . Male female patient age ≥ 20 year old 2 . A minimum 3month history stable angina 3 . Patients diagnosis coronary artery disease ( CAD ) 4 . Patients present symptom stable angina withdrawn antianginal drug give require background therapy least 7 day qualify enter study perform 1st ETT qualify test 5 . Patients develop exerciseinduced ECG ischemiai two qualify exercise treadmill testsii . The difference twoiii test ≤ 20 % long test ≤ 1 minute i. Exerciseinduced ECG ischemia define new development horizontal downsloping STsegment depression ≥1mm 6080ms J point ; patient baseline ST depression rest ( &lt; 1mm ) , qualify ST segment depression define additional ST depression least 1 mm rest value ii . Exercise treadmill test ( ETT ) perform Modified Bruce Protocol . iii . Two qualify test conduct 1 week apart , 3rd ETT test perform ≤ 3 day difference previous two qualify ETTs &gt; 20 % long test &gt; 1 minute 6 . Willing able provide write informed consent 1 . Factors might compromise ECG ETT interpretation Patients rest STsegment depression ≥ 1mm lead Left bundlebranch block Patients implant pacemaker Patients Digitalis therapy 2 . Patients family history ( congenital ) long QT syndrome 3 . Patients congenital heart disease 4 . Patients uncorrected valvular heart disease 5 . Patients unstable angina , MI , coronary revascularization procedure ≤ 2 month prior enter study 6 . Female pregnant/lactating planning pregnant , female childbearing potential* use medically recognize method contraception *Other surgically sterilize ( define undergone hysterectomy bilateral oophorectomy bilateral salpingectomy ; tubal ligation alone consider sufficient ) one year postmenopausal . 7 . Patients one follow condition : New York Heart Association ( NYHA ) Class III Class IV congestive heart failure ( CHF ) QTc &gt; 450 msec screen Active myocarditis , pericarditis , hypertrophic cardiomyopathy Uncontrolled hypertension ( define SBP &gt; 180 mmHg ) Voltage criterion leave ventricular hypertrophy absence repolarization abnormality exclusion criterion 8 . Use investigational product ≤ 4 week prior screen 9 . Patients severe hepatic disease ( e.g. , liver cirrhosis ) 10 . Patients impaired renal function ( define serum Cr &gt; 1.5 mg/dl ) 11 . Patients condition disease consider suitable study investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>RNTA06</keyword>
	<keyword>RANCAD</keyword>
</DOC>